Fellowship · Salt Lake City, UT
Sponsored by University of Utah Health
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
The New England journal of medicine · 2025 · 187 citations · Elizabeth Raetz
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
The New England journal of medicine · 2023 · 303 citations · Richard Lemons
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 326 citations · Michael Pulsipher
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nature medicine · 2024 · 168 citations · Nicholas Whipple
The genomic landscape of pediatric acute lymphoblastic leukemia.
Nature genetics · 2022 · 338 citations · Elizabeth Raetz
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA · 2021 · 318 citations · Elizabeth Raetz
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.
Nature · 2024 · 140 citations · Elizabeth Raetz
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 146 citations · Douglas Fair